Page 31 - Demo

CUAJ %u2022 APRIL 2025 %u2022 VOLUME 19, ISSUE 4 101Guideline: IC/BPSidentified through the systematic process of producing this guideline can help direct future research efforts to provide better support for the treatments we offer our patients with IC/BPS. COMPETING INTERESTS: Dr. Doiron has received research grants from Immunotek and Redleaf Medical. Dr. Andrews has been an advisory board member for Abbvie. Dr. Nadeau has been an advisory board member for Allergan/Abbvie, Astellas, and Hollister; has given talks supported by Allergan/Abbvie, Astellas, Laborie Pfizer, and Searchlight Pharma; and has received research grants from Searchlight Pharma/Boston Scientific. Dr. Cox has been an advisory board member and speaker for Abbvie. Dr. Nguyen has been an advisory board member for Allergan and Astellas; a speaker for Astellas; and has received grants and/or honoraria from Allergan, Astellas, and Pfizer. Dr. Nickel has been a consultant for Inmunotek, OM Pharma, and Redleaf Medical; has received honoraria from Immunotek (received vaccine Uromune %u201cin kind%u201d from Inmunotek for clinical trial); and has participated in clinical trials supported by Inmunotek (MV140 First in North America Study with %u201cin kind%u2019 support from Inmunotek) and MIcroGenDx (urinary microbiome study); all support %u201cin kind%u201d (Dr. Nickel or his institution did not receive direct financial support). The remaining authors and reviewers do not report any competing personal or financial interests related to this work.REFERENCES1. Hanno P, Dmochowski R. Status of international consensus on interstitial cystitis/bladder pain syndrome/painful bladder syndrome: 2008 snapshot. Neurourol Urodyn 2009;28:274-86. https://doi.org/10.1002/nau.206872. Clemens JQ, Erickson DR, Varela NP, Lai HH. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol 2022;208:34-42. https://doi.org/10.1097/JU.00000000000027563. Anger JT, Dallas KB, Bresee C, et al. National prevalence of IC/BPS in women and men utilizing veterans health administration data. Front Pain Res (Lausanne) 2022;3:925834. https://doi.org/10.3389/fpain.2022.9258344. Ito T, Ueda T, Honma Y, Takei M. Recent trends in patient characteristics and therapeutic choices for interstitial cystitis: Analysis of 282 Japanese patients. Int J Urol 2007;14:1068-70. https://doi.org/10.1111/j.1442-2042.2007.01863.x5. Clemens JQ, Calhoun EA, Litwin MS, et al. A survey of primary care physician practices in the diagnosis and management of women with interstitial cystitis/painful bladder syndrome. Urology 2010;76:323-8. https://doi.org/10.1016/j.urology.2009.12.0476. Warren JW, Meyer WA, Greenberg P, et al. Using the International Continence Society%u2019s definition of painful bladder syndrome. Urology 2006;67:1138-42; discussion 42-3. https://doi.org/10.1016/j.urology.2006.01.0867. Bassaly R, Downes K, Hart S. Dietary consumption triggers in interstitial cystitis/bladder pain syndrome patients. Female Pelvic Med Reconstr Surg 2011;17:36-9. https://doi.org/10.1097/SPV.0b013e3182044b5c8. Clemens JQ, Bogart LM, Liu K, et al. Perceptions of %u201curgency%u201d in women with interstitial cystitis/bladder pain syndrome or overactive bladder. Neurourol Urodyn 2011;30:402-5. https://doi.org/10.1002/nau.209749. Tincello DG, Walker AC. Interstitial cystitis in the UK: Results of a questionnaire survey of members of the Interstitial Cystitis Support Group. Eur J Obstet Gynecol Reprod Biol2005;118:91-5. https://doi.org/10.1016/j.ejogrb.2004.06.01210. Dubinskaya A, Tholemeier LN, Erickson T, et al. Prevalence of overactive bladder symptoms among women with interstitial cystitis/bladder pain syndrome. Female Pelvic Med Reconstr Surg 2022;28:e115-e9. https://doi.org/10.1097/SPV.000000000000116611. Bendrick TR, Sitenga GL, Booth C, et al. The implications of mental health and trauma in interstitial cystitis. Health Psychol Res 2022;10:40321. https://doi.org/10.52965/001c.4032112. Peters KM, Carrico DJ, Kalinowski SE, et al. Prevalence of pelvic floor dysfunction in patients with interstitial cystitis. Urology 2007;70:16-8. https://doi.org/10.1016/j.urology.2007.02.06713. Ottem DP, Teichman JM. What is the value of cystoscopy with hydrodistension for interstitial cystitis? Urology 2005;66:494-9. https://doi.org/10.1016/j.urology.2005.04.01114. Teichman JM, Parsons CL. Contemporary clinical presentation of interstitial cystitis. Urology2007;69:41-7. https://doi.org/10.1016/j.urology.2006.08.111115. Koziol JA. Epidemiology of interstitial cystitis. Urol Clin North Am 1994;21:7-20. https://doi.org/10.1016/S0094-0143(21)00587-516. Mazeaud C, Rigaud J, Levesque A, et al. Stratification of patients with interstitial cystitis/bladder pain syndrome according to the anatomical bladder capacity. Urology 2019;123:87-92. https://doi.org/10.1016/j.urology.2018.07.04617. Gomes CM, Sanchez-Ortiz RF, Harris C, et al. Significance of hematuria in patients with interstitial cystitis: Review of radiographic and endoscopic findings. Urology 2001;57:262-5. https://doi.org/10.1016/S0090-4295(00)00918-318. Keller ML, McCarthy DO, Neider RS. Measurement of symptoms of interstitial cystitis. A pilot study. Urol Clin North Am 1994;21:67-71. https://doi.org/10.1016/S0094-0143(21)00593-019. O%u2019Leary MP, Sant GR, Fowler FJ, Jr., et al. The interstitial cystitis symptom index and problem index. Urology 1997;49:58-63. https://doi.org/10.1016/S0090-4295(99)80333-120. Parsons CL, Dell J, Stanford EJ, et al. Increased prevalence of interstitial cystitis: Previously unrecognized urologic and gynecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity. Urology 2002;60:573-8. https://doi.org/10.1016/S0090-4295(02)01829-021. Clemens JQ, Calhoun EA, Litwin MS, et al. Validation of a modified National Institutes of Health chronic prostatitis symptom index to assess genitourinary pain in both men and women. Urology 2009;74:983-7, quiz 7 e1-3. https://doi.org/10.1016/j.urology.2009.06.07822. Forrest JB, Mishell DR, Jr. Breaking the cycle of pain in interstitial cystitis/painful bladder syndrome: Toward standardization of early diagnosis and treatment: Consensus panel recommendations. J Reprod Med 2009;54:3-14.23. Lai HH, Newcomb C, Harte S, et al. Comparison of deep phenotyping features of UCPPS with and without Hunner lesion: A MAPP-II Research Network Study. Neurourol Urodyn2021;40:810-8. https://doi.org/10.1002/nau.2462324. Messing E, Pauk D, Schaeffer A, et al. Associations among cystoscopic findings and symptoms and physical examination findings in women enrolled in the Interstitial Cystitis Data Base (ICDB) Study. Urology 1997;49:81-5. https://doi.org/10.1016/S0090-4295(99)80336-725. Nigro DA, Wein AJ, Foy M, et al. Associations among cystoscopic and urodynamic findings for women enrolled in the Interstitial Cystitis Data Base (ICDB) Study. Urology 1997;49:86-92. https://doi.org/10.1016/S0090-4295(99)80337-926. Peters KM, Killinger KA, Mounayer MH, Boura JA. Are ulcerative and nonulcerative interstitial cystitis/painful bladder syndrome 2 distinct diseases? A study of coexisting conditions. Urology 2011;78:301-8. https://doi.org/10.1016/j.urology.2011.04.03027. Fall M, Nordling J, Cervigni M, et al. Hunner lesion disease differs in diagnosis, treatment and outcome from bladder pain syndrome: An ESSIC working group report. Scand J Urol2020;54:91-8. https://doi.org/10.1080/21681805.2020.173094828. Furuya R, Masumori N, Furuya S, et al. Glomerulation observed during transurethral resection of the prostate for patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia is a common finding but no predictor of clinical outcome. Urology 2007;70:922-6. https://doi.org/10.1016/j.urology.2007.06.115329. Tissot WD, Diokno AC, Peters KM. A referral center%u2019s experience with transitional cell carcinoma misdiagnosed as interstitial cystitis. J Urol 2004;172:478-80. https://doi.org/10.1097/01.ju.0000132323.89037.7330. Nickel JC, Shoskes D, Irvine-Bird K. Clinical phenotyping of women with interstitial cystitis/painful bladder syndrome: A key to classification and potentially improved management. J Urol 2009;182:155-60. https://doi.org/10.1016/j.juro.2009.02.12231. Landis JR, Williams DA, Lucia MS, et al. The MAPP research network: Design, patient characterization and operations. BMC Urol 2014;14:58. https://doi.org/10.1186/1471-2490-14-5832. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-6. https://doi.org/10.1136/bmj.39489.470347.AD33. Alonso-Coello P, Sch%u00fcnemann HJ, Moberg J, et al. GRADE Evidence to Decision (EtD) frameworks: A systematic and transparent approach to making well informed healthcare choices. 1: Introduction. BMJ 2016;353:i2016. https://doi.org/10.1136/bmj.i201634. Guyatt GH, Oxman AD, Montori V, et al. GRADE guidelines: 5. Rating the quality of evidence-publication bias. J Clin Epidemiol 2011;64:1277-82. https://doi.org/10.1016/j.jclinepi.2011.01.01135. Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines 6. Rating the quality of evidence-imprecision. J Clin Epidemiol 2011;64:1283-93. https://doi.org/10.1016/j.jclinepi.2011.01.01236. Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines: 7. Rating the quality of evidence-inconsistency. J Clin Epidemiol 2011;64:1294-302. https://doi.org/10.1016/j.jclinepi.2011.03.017